Author:
Smeal B C,Bender L,Jungkind D L,Hastie A T
Abstract
Of 72 clinical isolates of Pseudomonas aeruginosa examined for simultaneous production of secondary metabolites, 86% produced 2-alkyl-4-hydroxyquinolines, 75% produced rhamnolipids, and 58% produced phenazines, including pyocyanin. Whereas isolates producing two or one constituted smaller groups, 39% released all three metabolites. Metabolite production did not appear to influence site of infection.
Publisher
American Society for Microbiology
Reference21 articles.
1. Toxic activity against alveolar macrophages of products of Pseudomonas aeruginosa isolated from respiratory and nonrespiratory sites;Dujaili A. H.;J. Hyg.,1976
2. Formation of hemolysin by strains of Pseudomonas aeruginosa;Altenbern R. A.;Can. J. Microbiol.,1966
3. The site of the activity of extracellular products of Pseudomonas aeruginosa in the electron-transport chain in mammalian cell respiration;Armstrong A. V.;J. Med. Microbiol.,1971
4. The effect of pyocyanin on human skin cells and leukocytes;Cruickshank C. N. D.;Br. J. Exp. Pathol.,1953
5. Gilardi G. L. 1985. Pseudomonas p. 350-372. In E. H. Lennette A. Balows W. J. Hausler Jr. and H. J. Shadomy (ed.) Manual of clinical microbiology 4th ed. American Society for Microbiology Washington D.C.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献